ASHLEY HANEY: Open Payments
NPI 1770286346 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $75 |
| Pharmacosmos Therapeutics Inc. | 2 | $47 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $30 |
| La Jolla Pharmaceutical Company | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $16 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: KEYTRUDA, MONOFERRIC, Orserdu, DATROWAY, GIAPREZA, LIBTAYO, ERLEADA, DARZALEX.
Industry payments across AL — which companies pay providers there.
